Q3 2025 Amarin Corporation PLC Earnings Call Transcript
Key Points
- Amarin Corp PLC (AMRN) has transitioned to a fully partnered commercial model across international ex-US markets, leveraging a global syndicate of 7 reputable partners.
- The partnership with Recordati in Europe is progressing well, with a smooth transition and sustained momentum in commercial operations.
- VASCEPA maintains a greater than 50% share of the IPE market in the US, demonstrating resilience against generic competition.
- The company achieved a 17% increase in total net revenue compared to the prior year, driven by higher US sales.
- Amarin Corp PLC (AMRN) is realizing significant operating expense savings, with a 47% reduction in SG&A expenses compared to the prior year.
- The transition to a partnered model in Europe has led to variability in product revenue, with potential fluctuations in quarterly financial results.
- Rest of the world revenue declined by 50% compared to Q2 2024, reflecting variability in supply shipments and market demand.
- The company is still incurring restructuring expenses, with $9.4 million reported in Q3 2025, impacting overall profitability.
- Gross margin percentages are expected to decline as the company moves to a partnered model, affecting overall financial performance.
- The impact of the FDA's updated labeling on fenofibrates remains uncertain, with potential challenges in changing prescribing practices and payer decisions.
Welcome to Amarin Corporation's conference call to discuss its third quarter 2025 financial results. I would like to turn the conference call over to Bob Burrows, Investor Relations for Amarin.
Good morning. Again, I'm Bob Burrows, Amarin's investor relations contact. For those that don't know me, for nearly 30 years, I've served as an in-house investor relations officer at various public companies, and I've been a consultant for the Amarin team since August of 2024.
Thank you for your time and attention this morning as we discuss Amarin's third quarter of 2025 financial results. Joining me with prepared comments are Aaron Berg, President and Chief Executive Officer, and Peter Fishman, Chief Financial Officer. Other members of the senior management team will be available if needed during the Q&A session that will follow these prepared comments.
Turning to today's agenda, Aaron will provide a state of the company, and Pete will walk through the numbers. In terms of important
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
